Usefulness of cytology pellets of bronchoscopy for next-generation sequencing (NGS)

Usefulness of cytology pellets of bronchoscopy for next-generation sequencing (NGS) - Usefulness of cytology pellets of bronchoscopy for next-generation sequencing (NGS)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052050

Enrollment

129

Registered

2023-09-04

Start date

2023-07-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients for whom information on medical treatment and prognosis can be obtained from medical records Patients enrolled in LC-SCRUM-Asia after bronchoscopy for primary lung cancer at Kobe University Hospital Patients over 20 years old

Exclusion criteria

Exclusion criteria: Patients who have requested not to participate in this study based on publicly available information

Design outcomes

Primary

Measure	Time frame
To investigate the success rate of genetic mutation analysis by oncomine of specimens obtained from tissue samples and cytology pellets in patients diagnosed with primary lung cancer by bronchoscopy and enrolled in LC-SCRUM-Asia, and to examine the usefulness of the cytology pellet.	—

Countries

Japan

Contacts

Public ContactChihiro Mimura

Kobe University Graduate School of Medicine Division of Respiratory Medicine, Department of Internal Medicine,

f9s5m1s3@gmail.com0783825660

Outcome results